Life science companies can now apply to a new £20 million fund to expand manufacturing in the UK.
The Medicines and Diagnostics Manufacturing Transformation Fund, designed to boost the UK’s ability to respond to future pandemics is open for applications with a deadline of 30 June 2021.
It is hoped that the new £20m fund will open up economic and investment opportunities for manufacturers across the whole of England, Northern Ireland, Scotland and Wales.
Business Secretary Kwasi Kwarteng commented: “This £20m investment will harness the best in UK manufacturing and fund cutting-edge medical technologies to protect the British public in 2021 and beyond.
“This will not only boost the UK’s already strong vaccine and medicine portfolio but support top quality, local jobs across the country and put the UK in a formidable position to continue responding to the most pressing global challenges of our time.” More details
